Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Prestige Consumer Healthcare (PBH)
NYSE:PBH
RESEARCH TOOLSreports
Prestige Consumer Healthcare (PBH) Stock Price & Analysis
101 Followers
PBH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$52.90 - $75.31
Previous Close$62.8
Volume244.91K
Average Volume (3M)249.06K
Market Cap
$3.13B
Enterprise Value$4.28B
Total Cash (Recent Filing)$63.62M
Total Debt (Recent Filing)$1.21B
Price to Earnings (P/E)15.1
Beta0.49
Next Earnings
Aug 01, 2024EPS Estimate
$0.86Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.17
Shares Outstanding49,915,366
10 Day Avg. Volume310,734
30 Day Avg. Volume249,057
Standard Deviation0.07
R-Squared0.16
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-2.49
Price to Sales (P/S)2.78
Price to Cash Flow (P/CF)10.90
P/FCF Ratio10.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.78
Enterprise Value/Gross Profit6.85
Enterprise Value/Ebitda13.73
Forecast
1Y Price Target
$77.50Price Target Upside20.51% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Prestige Consumer Healthcare News
PremiumCompany Announcements
Prestige Consumer Healthcare Announces Buyback, Shares Financials
PremiumCompany Announcements
Prestige Consumer Healthcare Elects Pfizer Veteran John F. Kelly to Board
Bulls Say, Bears Say
Bulls Say
Capital Allocation StrategyNew capital allocation strategy indicates a focus on investing in brands, pursuing accretive M&A, share repurchases, and further deleveraging after reaching leverage goals.
Financial PerformancePrestige Consumer Health's management team highlighted strong portfolio of niche brands leading their respective categories and driving strong free cash flow.
Growth StrategyManagement's upbeat outlook on international business outpacing long-term growth goal and recent performance of US business exceeding total growth expectations.
Bears Say
Earnings Shortfall4Q EPS misses on supply chain disruption.
Profitability ConcernsSales decline led to EBIT margin deleverage and an adjusted EPS of $1.02, missing the Street at $1.14.
Supply Chain DisruptionSupply chain challenges were unique one-offs driven by third-party manufacturers.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PBH FAQ
What was Prestige Consumer Healthcare’s price range in the past 12 months?
Prestige Consumer Healthcare lowest stock price was $52.90 and its highest was $75.31 in the past 12 months.
What is Prestige Consumer Healthcare’s market cap?
Currently, no data Available
When is Prestige Consumer Healthcare’s upcoming earnings report date?
Prestige Consumer Healthcare’s upcoming earnings report date is Aug 01, 2024 which is in 61 days.
How were Prestige Consumer Healthcare’s earnings last quarter?
Prestige Consumer Healthcare released its earnings results on May 14, 2024. The company reported $1.02 earnings per share for the quarter, missing the consensus estimate of $1.139 by -$0.119.
Is Prestige Consumer Healthcare overvalued?
According to Wall Street analysts Prestige Consumer Healthcare’s price is currently Undervalued.
Does Prestige Consumer Healthcare pay dividends?
Prestige Consumer Healthcare does not currently pay dividends.
What is Prestige Consumer Healthcare’s EPS estimate?
Prestige Consumer Healthcare’s EPS estimate is $0.86.
How many shares outstanding does Prestige Consumer Healthcare have?
Prestige Consumer Healthcare has 49,915,367 shares outstanding.
What happened to Prestige Consumer Healthcare’s price movement after its last earnings report?
Prestige Consumer Healthcare reported an EPS of $1.02 in its last earnings report, missing expectations of $1.139. Following the earnings report the stock price went down -7.01%.
Which hedge fund is a major shareholder of Prestige Consumer Healthcare?
Among the largest hedge funds holding Prestige Consumer Healthcare’s share is Ariel Investments LLC. It holds Prestige Consumer Healthcare’s shares valued at 186M.
---
Prestige Consumer Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$77.50 (20.51% Upside)
$77.50 (20.51% Upside)
Blogger Sentiment
Bullish
PBH Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 40.7K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
8.27%
12-Months-Change
Fundamentals
Return on Equity
13.50%
Trailing 12-Months
Asset Growth
-1.11%
Trailing 12-Months
Company Description
Prestige Consumer Healthcare
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare, and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.
---
PBH Company Deck
---
PBH Earnings Call
Q4 2024
0:00 / 0:00
---
PBH Stock 12 Month Forecast
Average Price Target
$77.50
▲(20.51% Upside)
Technical Analysis
Best Analysts Covering PBH
1 Year
1 Year Success Rate
4/7 ratings generated profit
1 Year Average Return
+0.44%
reiterated a buy rating 13 days ago
Copying Susan Anderson's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +0.44% per trade.
---